{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:41:44Z","timestamp":1792640504958,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-14005-y","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T02:45:25Z","timestamp":1785120325000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["HIV-1 genotypic patterns in antiretroviral-na\u00efve and treated patients in the integrase inhibitor era in Morocco"],"prefix":"10.1186","volume":"26","author":[{"given":"Maryam","family":"Ahmina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hicham El","family":"Annaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Reggad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Lamrak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Rida","family":"Tagajdid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachid","family":"Abi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Elqatni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelilah","family":"Laraqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safae","family":"Elkochri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elarbi","family":"Bouaiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadoua El","family":"Amraoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yassine","family":"Elbnaissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imane","family":"Hamdouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bouchra El","family":"Mchichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Touil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Ennibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idriss","family":"Amine Lahlou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"key":"14005_CR1","unstructured":"UNAIDS. Global HIV & AIDS statistics\u2014fact sheet [Internet]. [cited 2025 Apr 13]. Available from: https:\/\/www.unaids.org\/en\/resources\/fact-sheet."},{"key":"14005_CR2","unstructured":"HIV data and statistics [Internet]. [cited 2025 Jul 27]. Available from: https:\/\/www.who.int\/teams\/global-hiv-hepatitis-and-stis-programmes\/hiv\/strategic-information\/hiv-data-and-statistics."},{"key":"14005_CR3","unstructured":"World Health Organization. HIV statistics, globally and by WHO region. Geneva: World Health Organization; 2024."},{"key":"14005_CR4","doi-asserted-by":"crossref","unstructured":"Bekker LG, Beyrer C, Mgodi N, Lewin SR, Delany-Moretlwe S, Taiwo B, et al. HIV infection. Nat Rev Dis Primers [Internet]. 2023 [cited 2025 Dec 8];9(1):42. Available from: https:\/\/www.nature.com\/articles\/s41572-023-00452-3.","DOI":"10.1038\/s41572-023-00452-3"},{"key":"14005_CR5","unstructured":"Shuaib BI, Pius OO, Dutsinma UA. The evolution of HIV-1 drug resistance and genetic variability under HAART pressure [Internet]. 2025 [cited 2025 Dec 9]. Available from: https:\/\/www.intechopen.com\/online-first\/1204248."},{"key":"14005_CR6","doi-asserted-by":"crossref","unstructured":"Santoro MM, Perno CF. HIV-1 genetic variability and clinical implications. Int Sch Res Notices [Internet]. 2013 [cited 2025 Dec 9];2013(1):481314. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1155\/2013\/481314.","DOI":"10.1155\/2013\/481314"},{"key":"14005_CR7","doi-asserted-by":"publisher","unstructured":"Bertagnolio S, Hermans L, Jordan MR, Avila-Rios S, Iwuji C, Derache A, et al. Clinical impact of pretreatment human immunodeficiency virus drug resistance in people initiating nonnucleoside reverse transcriptase inhibitor-containing antiretroviral therapy: a systematic review and meta-analysis. J Infect Dis [Internet]. 2021 [cited 2025 Dec 9];224(3):377\u201388. Available from: https:\/\/doi.org\/10.1093\/infdis\/jiaa683.","DOI":"10.1093\/infdis\/jiaa683"},{"key":"14005_CR8","doi-asserted-by":"crossref","unstructured":"Tang MW, Shafer RW. HIV-1 antiretroviral resistance. Drugs [Internet]. 2012 [cited 2025 Dec 9];72(9):e1\u201325. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3689909\/.","DOI":"10.2165\/11633630-000000000-00000"},{"key":"14005_CR9","doi-asserted-by":"crossref","unstructured":"Clutter DS, Jordan MR, Bertagnolio S, Shafer RW. HIV-1 drug resistance and resistance testing. Infect Genet Evol [Internet]. 2016 [cited 2021 Oct 12];46:292\u2013307. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567134816303690.","DOI":"10.1016\/j.meegid.2016.08.031"},{"key":"14005_CR10","doi-asserted-by":"publisher","first-page":"846943","DOI":"10.3389\/fmicb.2022.846943","volume":"13","author":"MNS Miranda","year":"2022","unstructured":"Miranda MNS, Pingarilho M, Pimentel V, Martins M, do RO, Kaiser R, Seguin-Devaux C, et al. Trends of Transmitted and Acquired Drug Resistance in Europe From 1981 to 2019: A Comparison Between the Populations of Late Presenters and Non-late Presenters. Front Microbiol. 2022;13:846943.","journal-title":"Front Microbiol"},{"key":"14005_CR11","unstructured":"van de Laar MJ, Bosman A, Pharris A, Andersson E, Assoumou L, Ay E, et al. Piloting a surveillance system for HIV drug resistance in the European Union. Euro Surveill [Internet]. 2019 [cited 2025 Dec 9];24(19):1800390. Available from: https:\/\/www.eurosurveillance.org\/content\/10.2807\/1560-7917.ES.2019.24.19.1800390;jsessionid=O6HEWzwFa_bfhF2W6x0YCGQER2GYabNZFdEuffH2.i-0b3d9850f4681504f-ecdclive."},{"key":"14005_CR12","doi-asserted-by":"crossref","unstructured":"Khodadad N, Hashempour A, Nazar MMKA, Ghasabi F. Evaluating HIV drug resistance in the Middle East and North Africa and its associated factors: a systematic review. Virol J [Internet]. 2025 [cited 2025 Sep 5];22:112. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC12016335\/.","DOI":"10.1186\/s12985-025-02740-8"},{"key":"14005_CR13","doi-asserted-by":"crossref","unstructured":"Kavuraya AN, Mselle T, Mpenda FN. The genetic diversity and drug resistance patterns of HIV-1 pol gene in East Africa. Adv Virol [Internet]. 2025 [cited 2025 Dec 9];2025:2801818. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12539661\/.","DOI":"10.1155\/av\/2801818"},{"key":"14005_CR14","unstructured":"Rapport national SIDA 2024 Maroc [Internet]. Morocco: Minist\u00e8re de la Sant\u00e9 et de la Protection Sociale; 2024 [cited 2025 Apr 1]. Available from: https:\/\/www.sante.gov.ma\/Documents\/2024\/11\/Rapport%20SIDA%202024%20VF%20.pdf."},{"key":"14005_CR15","unstructured":"UNAIDS. Maroc [Internet]. [cited 2024 Dec 30]. Available from: https:\/\/www.unaids.org\/fr\/regionscountries\/countries\/morocco."},{"key":"14005_CR16","unstructured":"World Health Organization. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach [Internet]. [cited 2025 Apr 13]. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240031593."},{"key":"14005_CR17","doi-asserted-by":"crossref","unstructured":"Ahmina M, El Annaz H, Lamrak N, Reggad A, Tagajdid MR, Abi R, et al. HIV-1 subtype diversity in Morocco: signals of change and implications for national surveillance. Infect Dis Rep [Internet]. 2025 [cited 2025 Oct 30];17(5):128. Available from: https:\/\/www.mdpi.com\/2036-7449\/17\/5\/128.","DOI":"10.3390\/idr17050128"},{"key":"14005_CR18","doi-asserted-by":"crossref","unstructured":"Moore H, Palumbo P, Notarte KI, Fogel J, Cummings V, Gamble T, et al. Performance of the Applied Biosystems HIV-1 genotyping kit with integrase. J Clin Microbiol. 2024;62.","DOI":"10.1128\/jcm.00136-24"},{"issue":"2","key":"14005_CR19","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1159\/000331998","volume":"55","author":"MW Tang","year":"2012","unstructured":"Tang MW, Liu TF, Shafer RW. The HIVdb system for HIV-1 genotypic resistance interpretation. Intervirology. 2012;55(2):98\u2013101.","journal-title":"Intervirology"},{"key":"14005_CR20","doi-asserted-by":"crossref","unstructured":"Mumtaz GR, Chemaitelly H, AlMukdad S, Osman A, Fahme S, Rizk NA, et al. Status of the HIV epidemic in key populations in the Middle East and North Africa: knowns and unknowns. Lancet HIV [Internet]. 2022 [cited 2024 Nov 1];9(7):e506\u201316. Available from: https:\/\/www.thelancet.com\/journals\/lanhiv\/article\/PIIS2352-3018(22)00093-5\/fulltext.","DOI":"10.1016\/S2352-3018(22)00093-5"},{"key":"14005_CR21","doi-asserted-by":"crossref","unstructured":"Collins S, Namiba A, Sparrowhawk A, Strachan S, Thompson M, Nakamura H. Late diagnosis of HIV in 2022: why so little change? HIV Med [Internet]. 2022 [cited 2025 Oct 30];23(11):1118\u201326. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1111\/hiv.13444.","DOI":"10.1111\/hiv.13444"},{"key":"14005_CR22","doi-asserted-by":"crossref","unstructured":"Karbasi A, Fordjuoh J, Abbas M, Iloegbu C, Patena J, Adenikinju D, et al. An evolving HIV epidemic in the Middle East and North Africa (MENA) region: a scoping review. Int J Environ Res Public Health [Internet]. 2023 [cited 2025 Sep 4];20(5):3844. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC10001308\/.","DOI":"10.3390\/ijerph20053844"},{"key":"14005_CR23","doi-asserted-by":"crossref","unstructured":"G\u00f6kengin D, Doroudi F, Tohme J, Collins B, Madani N. HIV\/AIDS: trends in the Middle East and North Africa region. Int J Infect Dis [Internet]. 2016;44:66\u201373. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1201971215002684.","DOI":"10.1016\/j.ijid.2015.11.008"},{"key":"14005_CR24","doi-asserted-by":"crossref","unstructured":"Sallam M, Al-Khatib AO, Sabra T, Al-Baidhani S, Al-Mahzoum K, Aleigailly MA, et al. Challenges in elucidating HIV-1 genetic diversity in the Middle East and North Africa: a review based on a systematic search. Viruses [Internet]. 2025;17(3). Available from: https:\/\/www.mdpi.com\/1999-4915\/17\/3\/336.","DOI":"10.3390\/v17030336"},{"key":"14005_CR25","doi-asserted-by":"publisher","unstructured":"Hemelaar J, Elangovan R, Yun J, Dickson-Tetteh L, Fleminger I, Kirtley S, et al. Global and regional molecular epidemiology of HIV-1, 1990\u20132015: a systematic review, global survey, and trend analysis. Lancet Infect Dis [Internet]. 2019 [cited 2024 Dec 19];19(2):143\u201355. Available from: https:\/\/doi.org\/10.1016\/S1473-3099(18)30647-9.","DOI":"10.1016\/S1473-3099(18)30647-9"},{"key":"14005_CR26","doi-asserted-by":"publisher","unstructured":"Nair M, Gettins L, Fuller M, Kirtley S, Hemelaar J. Global and regional genetic diversity of HIV-1 in 2010\u201321: systematic review and analysis of prevalence. Lancet Microbe [Internet]. 2024 [cited 2025 Apr 13];5(11). Available from: https:\/\/doi.org\/10.1016\/S2666-5247(24)00151-4.","DOI":"10.1016\/S2666-5247(24)00151-4"},{"issue":"8","key":"14005_CR27","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1089\/aid.2010.0284","volume":"27","author":"HE Annaz","year":"2011","unstructured":"Annaz HE, Recordon-Pinson P, Baba N, Sedrati O, Mrani S, Fleury H. Presence of drug resistance mutations among drug-naive patients in Morocco. AIDS Res Hum Retroviruses. 2011;27(8):917\u201320.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"8","key":"14005_CR28","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1089\/aid.2011.0278","volume":"28","author":"H El Annaz","year":"2012","unstructured":"El Annaz H, Recordon-Pinson P, Tagajdid R, Doblali T, Belefquih B, Oumakhir S, et al. Drug resistance mutations in HIV type 1 isolates from patients failing antiretroviral therapy in Morocco. AIDS Res Hum Retroviruses. 2012;28(8):944\u20138.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"6","key":"14005_CR29","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1089\/aid.2011.0225","volume":"28","author":"L Miri","year":"2012","unstructured":"Miri L, Ouladlahsen A, Kettani A, Bensghir R, Marhoum Elfilali K, Wakrim L. Characterization of protease resistance-associated mutations in HIV type 1 drug-naive patients following the increasing prevalence of the CRF02_AG strain in Morocco. AIDS Res Hum Retroviruses. 2012;28(6):571\u20137.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"5","key":"14005_CR30","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3855\/jidc.247","volume":"3","author":"K Bakhouch","year":"2009","unstructured":"Bakhouch K, Oulad-Lahcen A, Bensghir R, Blaghen M, Elfilali KM, Ezzikouri S, et al. The prevalence of resistance-associated mutations to protease and reverse transcriptase inhibitors in treatment-na\u00efve (HIV1)-infected individuals in Casablanca, Morocco. J Infect Dev Ctries. 2009;3(5):380\u201391.","journal-title":"J Infect Dev Ctries"},{"key":"14005_CR31","unstructured":"Ahmina M, Lamrak N, El Annaz H, Rida-Tagajdid M, Abi R, Elqatni M, et al. HIV-1 genotyping and drug resistance mutations in Morocco (2009\u20132024): a systematic review addressing critical gaps in molecular surveillance. AIDS Rev. 2025."},{"key":"14005_CR32","doi-asserted-by":"crossref","unstructured":"Kayinda F, Awor P, Mahaba T, Muganzi AM, Kigozi J, Olwedo PO, et al. Prevalence of HIV drug resistance, its correlates and common mutations among people living with HIV failing on ART in northern Uganda: a cross-sectional study. PLoS One [Internet]. 2025 [cited 2025 Nov 26];20(8):e0320623. Available from: https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0320623.","DOI":"10.1371\/journal.pone.0320623"},{"key":"14005_CR33","doi-asserted-by":"crossref","unstructured":"Rhee SY, Kassaye SG, Barrow G, Sundaramurthi JC, Jordan MR, Shafer RW. HIV-1 transmitted drug resistance surveillance: shifting trends in study design and prevalence estimates. J Int AIDS Soc [Internet]. 2020 [cited 2025 Nov 26];23(9):e25611. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1002\/jia2.25611.","DOI":"10.1002\/jia2.25611"},{"key":"14005_CR34","doi-asserted-by":"crossref","unstructured":"Villabona-Arenas CJ, Vidal N, Guichet E, Serrano L, Delaporte E, Gascuel O, Peeters M. In-depth analysis of HIV-1 drug resistance mutations in HIV-infected individuals failing first-line regimens in West and Central Africa. AIDS. 2016.","DOI":"10.1097\/QAD.0000000000001233"},{"issue":"Suppl 2","key":"14005_CR35","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/135965350801302S04","volume":"13","author":"DE Bennett","year":"2008","unstructured":"Bennett DE, Myatt M, Bertagnolio S, Sutherland D, Gilks CF. Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment. Antivir Ther. 2008;13(Suppl 2):25\u201336.","journal-title":"Antivir Ther"},{"key":"14005_CR36","doi-asserted-by":"crossref","unstructured":"Rhee SY, Liu T, Ravela J, Gonzales MJ, Shafer RW. Distribution of human immunodeficiency virus type 1 protease and reverse transcriptase mutation patterns in 4,183 persons undergoing genotypic resistance testing. Antimicrob Agents Chemother [Internet]. 2004 [cited 2026 Feb 3];48(8):3122\u20136. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC478552\/.","DOI":"10.1128\/AAC.48.8.3122-3126.2004"},{"key":"14005_CR37","doi-asserted-by":"publisher","unstructured":"Bacheler L, Jeffrey S, Hanna G, D\u2019Aquila R, Wallace L, Logue K, et al. Genotypic correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy. J Virol [Internet]. 2001 [cited 2026 Feb 3];75(11):4999\u20135008. Available from: https:\/\/doi.org\/10.1128\/JVI.75.11.4999-5008.2001.","DOI":"10.1128\/JVI.75.11.4999-5008.2001"},{"key":"14005_CR38","doi-asserted-by":"crossref","unstructured":"Geremia N, Basso M, De Vito A, Scaggiante R, Giobbia M, Battagin G, et al. Patterns of transmitted drug resistance mutations and HIV-1 subtype dynamics in ART-na\u00efve individuals in Veneto, Italy, from 2017 to 2024. Viruses [Internet]. 2024 [cited 2026 Feb 4];16(9):1393. Available from: https:\/\/www.mdpi.com\/1999-4915\/16\/9\/1393.","DOI":"10.3390\/v16091393"},{"key":"14005_CR39","doi-asserted-by":"publisher","unstructured":"Rhee SY, Taylor J, Fessel WJ, Kaufman D, Towner W, Troia P, et al. HIV-1 protease mutations and protease inhibitor cross-resistance. Antimicrob Agents Chemother [Internet]. 2010 [cited 2026 Feb 3];54(10):4253\u201361. Available from: https:\/\/doi.org\/10.1128\/aac.00574-10.","DOI":"10.1128\/aac.00574-10"},{"issue":"7","key":"14005_CR40","doi-asserted-by":"publisher","first-page":"470","DOI":"10.26719\/2024.30.7.470","volume":"30","author":"N Shalaka","year":"2024","unstructured":"Shalaka N. Retrospective study of the prevalence of acquired drug resistance after failed antiretroviral therapy in Libya. East Mediterr Health J. 2024;30(7):470\u201380.","journal-title":"East Mediterr Health J"},{"key":"14005_CR41","doi-asserted-by":"crossref","unstructured":"Crowell TA, Danboise B, Parikh A, Esber A, Dear N, Coakley P, et al. Pretreatment and acquired antiretroviral drug resistance among persons living with HIV in four African countries. Clin Infect Dis [Internet]. 2020 [cited 2025 Oct 28];73(7):e2311\u201322. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8492117\/.","DOI":"10.1093\/cid\/ciaa1161"},{"key":"14005_CR42","unstructured":"HIV drug resistance report 2021 [Internet]. [cited 2025 Nov 26]. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240038608."},{"key":"14005_CR43","unstructured":"HIV\/AIDS | WHO | Regional Office for Africa [Internet]. 2024 [cited 2024 Dec 19]. Available from: https:\/\/www.afro.who.int\/health-topics\/hivaids."},{"key":"14005_CR44","doi-asserted-by":"crossref","unstructured":"Hauser A, Goldstein F, Reichmuth ML, Kouyos RD, Wandeler G, Egger M, et al. Acquired HIV drug resistance mutations on first-line antiretroviral therapy in Southern Africa: systematic review and Bayesian evidence synthesis. J Clin Epidemiol [Internet]. 2022 [cited 2026 Feb 4];148:135\u201345. Available from: https:\/\/www.jclinepi.com\/article\/S0895-4356(22)00043-9\/fulltext.","DOI":"10.1016\/j.jclinepi.2022.02.005"},{"key":"14005_CR45","doi-asserted-by":"crossref","unstructured":"Miranda MNS, Pingarilho M, Pimentel V, Martins M do RO, Kaiser R, Seguin-Devaux C, et al. Trends of transmitted and acquired drug resistance in Europe from 1981 to 2019: a comparison between the populations of late presenters and non-late presenters. Front Microbiol [Internet]. 2022 [cited 2026 Feb 4];13. Available from: https:\/\/www.frontiersin.org\/journals\/microbiology\/articles\/10.3389\/fmicb.2022.846943\/full.","DOI":"10.3389\/fmicb.2022.846943"},{"issue":"5","key":"14005_CR46","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S1473-3099(15)00536-8","volume":"16","author":"TenoRes Study Group","year":"2016","unstructured":"TenoRes Study Group. Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study. Lancet Infect Dis. 2016;16(5):565\u201375.","journal-title":"Lancet Infect Dis"},{"key":"14005_CR47","unstructured":"Factors associated with HIV-1 resistance to integrase strand transfer inhibitors in Spain: implications for dolutegravir-containing regimens [Internet]. [cited 2026 Feb 4]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/36578581\/."},{"issue":"12","key":"14005_CR48","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.1093\/jac\/dkaa355","volume":"75","author":"E Ndashimye","year":"2020","unstructured":"Ndashimye E, Avino M, Olabode AS, Poon AFY, Gibson RM, Li Y, et al. Accumulation of integrase strand transfer inhibitor resistance mutations confers high-level resistance to dolutegravir in non-B subtype HIV-1 strains from patients failing raltegravir in Uganda. J Antimicrob Chemother. 2020;75(12):3525\u201333.","journal-title":"J Antimicrob Chemother"},{"key":"14005_CR49","volume-title":"Report of a WHO Meeting, 29\u201330 March 2022","author":"Update on the Transition to Dolutegravir-Based Antiretroviral Therapy","year":"2022","unstructured":"Update on the Transition to Dolutegravir-Based Antiretroviral Therapy. Report of a WHO Meeting, 29\u201330 March 2022. 1st ed. Geneva: World Health Organization; 2022.","edition":"1"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-14005-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-14005-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-14005-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:19:20Z","timestamp":1792639160000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-14005-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["14005"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-14005-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"assertion":[{"value":"18 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was performed in accordance with the Declaration of Helsinki and received ethical approval from the Ethics Committee of the Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco (Approval No. CERB 47\/23; 19 June 2023). Written informed consent was obtained from all participants.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all participants prior to enrollment in the study.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1862"}}